Top Markets
#1 Trillions Trillions +5,128.12%
#2 DeFiChain DeFiChain +1,700.88%
#3 Bedrock Bedrock +165.63%
#4 Siren Siren +128.69%
#5 inSure DeFi inSure DeFi +59.52%
#6 KONET KONET +56.82%
#7 Aria.AI Aria.AI +45.69%
#8 Banana For Scale Banana For Scale +45.24%
#9 Syndicate Syndicate +40.88%
#10 Janction Janction +36.48%
Coin of the day
Trillions Trillions
설정
언어
한국어
통화
USD
테마
Ovoca Bio plc Ovoca Bio plc

Ovoca Bio plc

OVB
주식 순위 #99999
Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the... Ovoca Bio plc, a clinical-stage biopharmaceutical company, engages in the development and commercialization of novel product candidates for the treatment of female sexual dysfunctions. It is developing BP-101, a medicinal treatment for premenopausal women with hypoactive sexual desire disorder, which is in phase II clinical study in Australia and New Zealand, and in phase III clinical trials in Russia. It also engages in mineral exploration, as well as provides support services. The company was formerly known as Ovoca Gold plc and changed its name to Ovoca Bio plc in July 2018. Ovoca Bio plc was incorporated in 1985 and is based in Dublin, Ireland.
주가
$0.09933121
시가총액
$29.15K
변동 (1일)
0.57%
변동 (1년)
449.49%
국가
IE
거래 Ovoca Bio plc (OVB)

카테고리

Healthcare
Ovoca Bio plc (OVB)의 발행 주식 수
June 2024 기준 발행 주식 수: 92.84M
Ovoca Bio plc의 최신 재무 보고서와 주가에 따르면 현재 발행 주식 수는 92.84M입니다. December 2023 말 기준 회사는 75.11M주를 발행했습니다. 발행 주식 수는 일반적으로 주식 분할이나 자사주 매입에 의해 영향을 받습니다.
Ovoca Bio plc (OVB)의 발행 주식 수 기록 (2001 ~ 2026)
매년 말 기준 발행 주식 수
연도 발행 주식 수 변화
2026 (TTM) 92.84M -99.55%
2024 20.72B 27,488.06%
2023 75.11M -7.91%
2022 81.56M 0.00%
2021 81.56M 0.00%
2020 81.56M 0.00%
2019 81.56M 0.00%
2018 81.56M 0.00%
2017 81.56M 0.00%
2016 81.56M 0.00%
2015 81.56M -6.64%
2014 87.36M 0.00%
2013 87.36M 0.00%
2012 87.36M -0.61%
2011 87.90M -0.64%
2010 88.46M 0.00%
2009 88.46M 1.33%
2008 87.30M 28.36%
2007 68.01M 45.51%
2006 46.74M 129.03%
2005 20.41M 194.39%
2004 6.93M 19.17%
2003 5.82M 1.55%
2002 5.73M 3.94%
2001 5.51M 0.00%
유사 기업 또는 경쟁사의 발행 주식 수
회사 발행 주식 수 차이 국가
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
 4.45B 4,691.14%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 253.90M 173.50%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 102.90M 10.84%
US
UCB SA UCB SA
UCB SA
UCB.BR
 190.00M 104.66%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 61.42M -33.84%
NL